<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Huang, Y.</title>
    <link>http://repub.eur.nl/res/aut/48481/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Dying for Oxygen: Roles of Hypoxia Inducible Factor 2a and 3a during lung development (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/32784/</link>
      <pubDate>2012-06-29T00:00:00Z</pubDate>
      <description>Congenital lung lesions comprise a broad spectrum of rare but clinically significant developmental
abnormalities, including congenital cystic adenomatoid malformation, bronchopulmonary sequestrations,
congenital lobar emphysema, and bronchogenic cysts, which are commonly surgically treated.
Although the terms congenital cystic adenomatoid malformation, bronchopulmonary sequestrations,
congenital lobar emphysema, and bronchogenic cysts are entrenched in clinical usage and comfortably
correspond to rigid pathologic definitions, there is a considerable overlap in the findings. Disregarding
the controversy about lesion nomenclature and classification, it is widely accepted that congenital lung
lesions result from perturbations in lung and airway embryogenesis. It is generally accepted that both
place (level in the tracheobronchial tree) and timing (gestational age) of the embryologic insult
correlates with the type of lesion and histopathology that is manifested. The objective of this review is
to briefly review normal lung development and to analyze the known molecular mechanisms underlying
those diseases.</description>
    </item>
  </channel>
</rss>